Although the overall trend in the proportion of trials with industry funding over time did not reach statistical significance ( p = 0.09), stratified analysis demonstrated that 34% of trials initiated between 2008 and 2015 had industry involvement compared with 50% of trials initiated between 2016 and 2022 ( p = 0.009).
← all excerpts
Recent Trends in Clinical Trials for Pediatric Sarcoma in the United States: An Analysis of ClinicalTrials.gov.
1
0.0900
0.0900